Publications by authors named "Chung-Feng Huang"

Claim this Profile
D
Dynamics of Cardiometabolic Risk Factors Are Linked to the Risk of Hypertension and Diabetes in MASLD.
Chin-I Shih, Ming-Lun Yeh, Yi-Hung Lin, Ping-Tsung Shih, Kuan-Ta Wu, Chung-Feng Huang, Jee-Fu Huang, Wan-Long Chuang

Kaohsiung J Med Sci· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nationwide hepatitis C virus microelimination in uremic patients undergoing maintenance hemodialysis in Taiwan.
Chung-Feng Huang, Po-Cheng Liang, Yu-Ju Wei, Chao-Chun Wu, Shi-Lun Wei

J Formos Med Assoc· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HCV elimination in hyperendemic areas: Experiences in Taiwan.
Chia-Yen Dai, Chung-Feng Huang, Wan-Long Chuang, Ming-Lung Yu

J Formos Med Assoc· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic Dysfunction-Associated Steatotic Liver Disease After Hepatitis C Virus Cure.
Chung-Feng Huang, Jee-Fu Huang, Ming-Lung Yu, Wan-Long Chuang

Kaohsiung J Med Sci· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term effectiveness of tenofovir alafenamide versus entecavir in treatment-naïve chronic hepatitis B: A REAL-B study.
Jie Li, Joanne Kimiko Liu, Angela Chau, Sovann Linden, Pei-Chien Tsai, Daniel Q Huang, Wan-Long Chuang, Jee-Fu Huang, Chung-Feng Huang

Am J Gastroenterol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Sofosbuvir/Velpatasvir Therapy on Extrahepatic Manifestations in Patients With Type 2 Diabetes and Chronic Hepatitis C: Insights From a Nationwide Hepatitis C Virus Registry in Taiwan.
Szu-Jen Wang, Te-Sheng Chang, Ching-Chu Lo, Chao-Hung Hung, Chien-Wei Huang, Jee-Fu Huang, Yi-Hsiang Huang, Chia-Sheng Huang, Wang-Long Chuang, Chung-Feng Huang

Kaohsiung J Med Sci· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FIB-4 Serves as a Referral Index for Coronary Artery Calcification in Patients With MASLD.
Ya-Chin Huang, Chih-Wen Wang, Jiun-Chi Huang, Po-Cheng Liang, Ming-Lun Yeh, Chao-Kuan Huang, Jee-Fu Huang, Wan-Long Chuang, Chung-Feng Huang

J Gastroenterol Hepatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival impact of hepatitis C virus eradication in patients with or without active hepatocellular carcinoma: A nationwide cohort study.
Teng-Yu Lee, Sheng-Shun Yang, Pei-Chien Tsai, Chung-Feng Huang, Chi-Yi Chen, Yi-Hsiang Huang, Chien-Wei Huang, Wan-Long Chuang

Eur J Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Point-of-Care Model for Hepatitis C Elimination in Remote Islands of Taiwan.
Tzu-Chun Lin, Pei-Chien Tsai, Chung-Feng Huang, Ming-Lun Yeh, Yu-Ju Wei, Jee-Fu Huang, Wan-Long Chuang

Kaohsiung J Med Sci· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Concurrent Steatotic Liver Disease and Chronic Hepatitis B on Treatment Response to Nucleos(t)ide Analogs.
Angela Chau, Jie Li, Dae Won Jun, Yao-Chun Hsu, Hidenori Toyoda, Daniel Q Huang, Rui Huang, Jee-Fu Huang, Chung-Feng Huang, Wan-Long Chuang

J Viral Hepat· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Steatotic Liver Disease-Related Polygenetic Risk Score Prediction of Hepatocellular Carcinoma in Nucleotide/Nucleoside Analog-Treated Chronic Hepatitis B.
Tyng-Yuan Jang, Chih-Wen Wang, Po-Cheng Liang, Yu-Ju Wei, Ming-Lun Yeh, Chao-Kuan Huang, Jee-Fu Huang, Chung-Feng Huang, Wan-Long Chuang

J Gastroenterol Hepatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of metabolic dysfunction on treatment responses to nucleos(t)ide analogues in chronic hepatitis B: a retrospective multi-center REAL-B cohort study.
Rui Huang, Dae Won Jun, Hidenori Toyoda, Yao-Chun Hsu, Huy Trinh, Daniel Q Huang, Jee-Fu Huang, Chung-Feng Huang, Wan-Long Chuang

EClinicalMedicine· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase IIb Trial for the Palliative Treatment of Patients With Primary Hepatic Malignancy Unable to Receive Curative Treatment: Efficacy of Colchicine.
Zu-Yau Lin, Ming-Lun Yeh, Po-Cheng Liang, Shinn-Cherng Chen, Chung-Feng Huang, Jee-Fu Huang, Wan-Long Chuang

Kaohsiung J Med Sci· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distribution, Characteristics, and Natural History of Diverse Types of Indeterminate Chronic Hepatitis B: A REAL-B Study.
Rui Huang, Ai-Thien Do, Hidenori Toyoda, Jie Li, Satoshi Yasuda, Daniel Q Huang, Wan-Long Chuang, Jee-Fu Huang, Chung-Feng Huang

Aliment Pharmacol Ther· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Hepatitis C Virus Clearance on Cardiovascular Risk: A Real-World Experience From the Nationwide Taiwan Hepatitis C Virus Registry.
Ping-Jen Hu, Pei-Chien Tsai, Chi-Yi Chen, Hsing-Tao Kuo, Chao-Hung Hung, Yi-Hsiang Huang, Chung-Feng Huang, Jee-Fu Huang

Kaohsiung J Med Sci· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impacts of metabolic syndrome diseases on long-term outcomes of chronic hepatitis B patients treated with nucleos(t)ide analogues.
Rui Huang, Dae Won Jun, Hidenori Toyoda, Yao-Chun Hsu, Huy Trinh, Daniel Q Huang, Jee-Fu Huang, Chung-Feng Huang, Wan-Long Chuang

Clin Mol Hepatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical impact of pharmacogenetic risk variants in a large chinese cohort.
Chun-Yu Wei, Ming-Shien Wen, Chih-Kuang Cheng, Yi-Jing Sheen, Tsung-Chieh Yao, Yen-Tsung Huang, Chin-Chou Huang, Yi-Hsiang Huang, Chun-Yao Huang, Chung-Feng Huang, Hui-Ping Chuang, Chih-Yang Huang

Nat Commun· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating let-7 Predicts Hepatic Fibrogenesis of 12-Month Post-Nucleos(t)ide Analog Treatment in Patients With Hepatitis B Virus.
Yi-Shan Tsai, Po-Cheng Liang, Yi-Hung Lin, Tyng-Yuan Jang, Yu-Ju Wei, Chung-Feng Huang, Jee-Fu Huang, Wan-Long Chuang

Kaohsiung J Med Sci· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term risk of depression and the impact of risk factors among chronic hepatitis C patients after successful antiviral therapy: A nationwide real-world Taiwanese cohort (T-COACH).
Ping-Jen Hu, Ming-Lung Yu, Ming-Yao Chen, Chi-Yi Chen, Hsing-Tao Kuo, Yi-Hsiang Huang, Chung-Feng Huang, Jee-Fu Huang

J Formos Med Assoc· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Type 2 diabetes mellitus as an independent predictor of significant fibrosis in treatment-naïve chronic hepatitis B patients with concurrent hepatic steatosis.
Jie Li, Liang Xu, Fajuan Rui, Sally Tran, Pei-Chien Tsai, Chung-Feng Huang, Jee-Fu Huang, Wan-Long Chuang

Hepatology· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renal Function in Chronic Hepatitis C Patients in Mongolia.
Gantogtokh Dashjamts, Amin-Erdene Ganzorig, Yumchinsuren Tsedendorj, Ankhzaya Batsaikhan, Dolgion Daramjav, Chung-Feng Huang

Diagnostics (Basel)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidences of Virological and Clinical Relapses After Cessation of Tenofovir Alafenamide, Tenofovir Disoproxil Fumarate, or Entecavir in Patients With HBeAg-Negative Chronic Hepatitis B.
Cheng-Hao Tseng, Teng-Yu Lee, Chi-Yi Chen, Chung-Feng Huang, Po-Yueh Chen

J Gastroenterol Hepatol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Hepatic and Extrahepatic Outcomes of Chronic Hepatitis C Patients After Sofosbuvir-Based Treatment (LONGHEAD Study).
Chung-Feng Huang, Jeong Heo, Rong-Nan Chien, Yang-Hyun Baek, Jia-Horng Kao, Jee-Fu Huang, Wan-Long Chuang

Infect Dis Ther· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitochondrial mt12361A>G increased risk of metabolic dysfunction-associated steatotic liver disease among non-diabetes.
Ming-Ying Lu, Yu-Ju Wei, Chih-Wen Wang, Po-Cheng Liang, Ming-Lun Yeh, Chung-Feng Huang, Jee-Fu Huang, Wan-Long Chuang

World J Gastroenterol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Posttreatment FIB-4 score change predicts hepatocellular carcinoma in chronic hepatitis C patients: Findings from the Taiwan hepatitis C registry program.
Hung-Wei Wang, Yu-Syuan Zeng, Chung-Feng Huang, Chi-Yi Chen, Hsing-Tao Kuo, Wan-Long Chuang, Jee-Fu Huang, Yi-Hsiang Huang, Chien-Wei Huang

J Formos Med Assoc· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis